IMATINIB TEVA PHARMA
400MG TBL FLM 30 I
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Resumption of marketing | 03.09.2020 | |||
Resumption of marketing | 15.08.2017 | |||
Interruption of marketing | 15.08.2017 |
0028028, 0028386 |
||
Placing on the market | 22.12.2016 |
All reports are available in the Overview.